Mondelez International, Inc. (MDLZ) Stock Price & Analysis
Mondelez International, Inc. (MDLZ) closed at USD 65.19 on Thursday, October 22, 2026, up 3.90% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 65.19; the Oct 22, 2026 session ranged USD 63.31–65.22 on volume of 9,144,068 shares. Market capitalization is —, with a 52-week range of USD 51.2–66.65 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MDLZ.md
Key facts (MDLZ)
- Last four reported quarters (through Jun 30, 2026): revenue $39.7B, net income $3.52B (8.9% margin), free cash flow $3.08B (SEC filings).
- Valuation: P/E 23.7x (avg 22.0x at the last 3 fiscal year-ends), EV/EBITDA 17.9x, net debt $17.0B.
- 4 of 80 tracked superinvestors hold MDLZ (13F, Q2 2026): 1 new, 0 added, 2 reduced, 1 unchanged.
- Analysts: Buy (mean 2.13 on a 1–5 scale) (23 analysts), mean target USD 69.09 (range 55–77).
- Total return with dividends: 1Y +10.7% vs S&P 500 +14.9%; 5Y +23.3% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 0.71, revenue estimate $9.99B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (MDLZ)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $28.7B | $31.5B | $36.0B | $36.4B | $38.5B | $39.7B |
| Gross profit | $11.3B | $11.3B | $13.8B | $14.3B | $10.9B | — |
| Operating income | $4.65B | $3.53B | $5.50B | $6.34B | $3.55B | $4.45B |
| Net income | $4.30B | $2.72B | $4.96B | $4.61B | $2.45B | $3.52B |
| EPS (diluted) | $3.04 | $1.96 | $3.62 | $3.42 | $1.89 | — |
| Free cash flow | $3.18B | $3.00B | $3.60B | $3.52B | $3.23B | $3.08B |
| Gross margin | 39.2% | 35.9% | 38.2% | 39.1% | 28.4% | — |
| Operating margin | 16.2% | 11.2% | 15.3% | 17.4% | 9.2% | 11.2% |
| Net margin | 15.0% | 8.6% | 13.8% | 12.7% | 6.4% | 8.9% |
| Revenue growth | +8.0% | +9.7% | +14.4% | +1.2% | +5.8% | — |
| Cash + short-term investments | $3.55B | $1.95B | $1.88B | $1.40B | $2.19B | — |
| Total debt | $19.3B | $22.6B | $19.0B | $17.7B | $19.9B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (MDLZ)
P/E 23.7x · P/S 2.1x · EV/EBITDA 17.9x · EV/Sales 2.5x · P/FCF 27.0x · P/B 3.1x · FCF yield 3.71% · Earnings yield 4.23% · Dividend yield (paid, TTM) 3.05% · Buyback yield (TTM) 1.13% · Net debt $17.0B · EV $100B
P/E at fiscal year-ends: Dec 2025 28.5x, Dec 2024 17.4x, Dec 2023 20.0x.
Superinvestors (SEC 13F-HR, Q2 2026) (MDLZ)
4 of 80 tracked investors hold MDLZ. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Lindsell Train | 5.64% | $148M | Reduced -28.0% | |
| Bill Nygren | Oakmark Funds | 0.42% | $319M | Reduced -2.0% |
| Lee Ainslie | Maverick Capital | 0.01% | $602K | New position |
| Dodge & Cox Funds | Dodge & Cox | <0.01% | $685K | Unchanged |
Analysts (MDLZ)
Consensus Buy (mean 2.13 on a 1–5 scale), 23 analysts; mean target USD 69.09 (low 55, high 77).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-16 | Barclays | Target raised | Overweight | $70 → $72 |
| 2026-10-16 | JP Morgan | Target lowered | Overweight | $72 → $71 |
| 2026-10-05 | Wells Fargo | Target lowered | Overweight | $70 → $65 |
| 2026-07-30 | Barclays | Target raised | Overweight | $68 → $70 |
| 2026-07-29 | BNP Paribas | Target raised | Outperform | $68 → $70 |
| 2026-07-29 | JP Morgan | Target raised | Overweight | $70 → $72 |
| 2026-07-29 | TD Cowen | Target raised | Buy | $67 → $70 |
Total return (dividends reinvested) (MDLZ)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +10.7% | +23.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +10.7% | +4.3% |
| Volatility (annualized) | 23.6% | 20.2% |
| Max drawdown | -15.7% (Oct 2025→Jan 2026) | -26.2% (Jan 2024→Dec 2025) |
MDLZ analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.71 | $0.76 | -6.2% | $9.99B | 17 |
| Next quarter (ends Dec 2026) | $0.94 | $0.94 | +0.6% | $10.74B | 17 |
| Current fiscal year (ends Dec 2026) | $3.05 | $3.05 | -0.0% | $40.09B | 23 |
| Next fiscal year (ends Dec 2027) | $3.36 | $3.37 | -0.4% | $41.20B | 23 |
MDLZ options: expected move
Options price a move of about ±3.9% (±$2.58) by Oct 30, 2026, which includes earnings on Oct 29, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 33.2% | ±3.9% |
| Nov 6, 2026 | 14 | 28.5% | ±4.6% |
| Nov 13, 2026 | 21 | 28.7% | ±5.6% |
| Nov 20, 2026 | 28 | 26.3% | ±5.9% |
| Nov 27, 2026 | 35 | 25.0% | ±6.3% |
| Dec 18, 2026 | 56 | 24.6% | ±7.7% |
| Jan 15, 2027 | 84 | 22.7% | ±8.9% |
| Mar 19, 2027 | 147 | 23.1% | ±11.7% |
30-day implied volatility 25.6% vs 22.6% realized over the last 30 trading days. Put/call ratio (volume) 0.17. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 65.19 |
|---|---|
| Change | ▲ 3.90% (up) |
| Previous Close | USD 65.19 |
| Open | USD 65.19 |
| Day Range | USD 63.31 – 65.22 |
| 52-Week Range | USD 51.2 – 66.65 |
| Volume | 9,144,068 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (MDLZ)
Nexqual's technical model rates MDLZ "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 66.87 (neutral) |
| vs SMA50 | Above (USD 61.83) |
| MACD | 0.81 (positive) |
Analyst Ratings (MDLZ)
Wall Street analysts rate MDLZ "Buy" based on 23 analysts, with a mean price target of USD 69.09 (range USD 55–77), per Nexqual as of October 23, 2026 at 09:26 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 23 |
| Mean Target | USD 69.09 |
| High Target | USD 77 |
| Low Target | USD 55 |
| Buy / Hold / Sell | 15 / 8 / 0 |
Earnings (MDLZ)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 0.71 |
| Revenue Estimate | $9.99B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.73 vs est 0.68 ▲ beat |
| 2026-03-31 | USD 0.67 vs est 0.61 ▲ beat |
| 2025-12-31 | USD 0.72 vs est 0.7 ▲ beat |
| 2025-09-30 | USD 0.73 vs est 0.71 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (MDLZ)
| Total Revenue | $39.67B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +4.10% |
| Gross Margin | +31.15% |
| Operating Margin | +21.98% |
| Profit Margin | +8.86% |
| ROE | +13.34% |
| Debt / Equity | 0.83 |
| Current Ratio | 0.6 |
| Total Cash | $1.72B |
| Total Debt | $22.06B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $3.08B (7.8% of revenue) |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financial Health Score (MDLZ)
Nexqual rates Mondelez International, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:26 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 31%, operating 22% (last 12 months) |
| Balance Sheet | Weak — $1.76B cash and investments vs $18.8B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $3.08B (last 4 quarters to Jun 2026, SEC), 8% margin |
| Efficiency | Mixed — ROE 13%, ROA 4.1% |
Ownership (MDLZ)
| Insider Ownership | +0.24% |
|---|---|
| Institutional Ownership | +89.44% |
| Shares Outstanding | 1.28B |
| Float | 1.27B |
| Short % of Float | +2.93% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Leadership (MDLZ)
Mondelez International, Inc. is led by Dirk Van de Put, Chairman & CEO, per Nexqual as of October 23, 2026 at 09:26 UTC.
| Chairman & CEO | Dirk Van de Put |
|---|---|
| Executive VP & COO | Luca Zaramella |
| Executive VP and Chief Marketing & Sales Officer | Martin Renaud |
| Executive VP & President of North America | Gustavo Carlos Valle |
| Executive VP & President of Europe | Volker Kuhn |
Major Backers & Investors (MDLZ)
Notable institutional backers of Mondelez International, Inc. include Capital Group, JPMorgan, Capital International Investors, according to Nexqual as of October 23, 2026 at 09:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Capital Group | 5.46% |
| JPMorgan | 4.76% |
| Capital International Investors | 3.96% |
| Invesco | 3.58% |
| AMERICAN MUTUAL FUND | 2.69% |
| Price (T.Rowe) Associates Inc | 2.58% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 9.24% |
| BlackRock | 8.3% |
| State Street | 4.67% |
| Geode Capital | 2.36% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HSY | The Hershey Company | USD 175.64 | ▲ 4.67% |
| TR | Tootsie Roll Industries, Inc. | USD 37.19 | ▲ 2.17% |
| CL | Colgate-Palmolive Company | USD 97.39 | ▲ 4.27% |
| MNST | Monster Beverage Corporation | USD 47.3 | ▲ 1.44% |
| TGT | Target Corporation | USD 158.11 | ▲ 3.76% |
| MO | Altria Group, Inc. | USD 76.07 | ▲ 3.03% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt